Mitchell Finer
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
- Genetics top 10%
- Virus-based gene therapy research
Papers in
-
- RNA Interference and Gene Delivery 5
- Viral Infectious Diseases and Gene Expression in Insects 4
- CRISPR and Genetic Engineering 3
- Genetics 10
- Virus-based gene therapy research 9
- Co-authors
- Helga Boedtker (5 shared papers)Qing Wang (2 shared papers)Paul Doty (3 shared papers)Sirpa Aho (1 shared paper)James G. McArthur (3 shared papers)Louis C. Gerstenfeld (2 shared papers)Ryan McGuinness (4 shared papers)Keegan S. Cooke (2 shared papers)
- Journals
- Nucleic Acids Research (2 papers)Cancer Research (2 papers)Molecular and Cellular Biology (2 papers)Human Gene Therapy (2 papers)Molecular Therapy (2 papers)
- Partner nations
- United StatesNetherlandsMalaysia
In The Last Decade
Mitchell Finer
23 papers receiving 654 citations
Peers
Comparison fields: 5 of 65
- Immunology and Allergy 96
- Genetics 308
- Oncology 245
- Immunology 160
- Molecular Biology 330
Countries citing papers authored by Mitchell Finer
This map shows the geographic impact of Mitchell Finer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Finer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Finer more than expected).
Fields of papers citing papers by Mitchell Finer
This network shows the impact of papers produced by Mitchell Finer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Finer. The network helps show where Mitchell Finer may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell Finer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 96 | |
| 2 | 1999 | 83 | |
| 3 | 1985 | 69 | |
| 4 | 2017 | 62 | |
| 5 | 1998 | 54 | |
| 6 | 1983 | 48 | |
| 7 | 1985 | 48 | |
| 8 | 1996 | 37 | |
| 9 | 2001 | 34 | |
| 10 | 1999 | 23 | |
| 11 | 2020 | 20 | |
| 12 | 1980 | 19 | |
| 13 | 2006 | 18 | |
| 14 | 2000 | 18 | |
| 15 | 1987 | 15 | |
| 16 | 1985 | 9 | |
| 17 | 2003 | 8 | |
| 18 | 2019 | 5 | |
| 19 | The Gene Pill and its therapeutic applications. | 2003 | 4 |
| 20 | 2016 | 3 |
About Mitchell Finer
Mitchell Finer is a scholar working on Molecular Biology, Genetics, Oncology, Immunology and Immunology and Allergy, having authored 24 papers that have together received 677 indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), CAR-T cell therapy research (6 papers), RNA Interference and Gene Delivery (5 papers), Cell Adhesion Molecules Research (5 papers), Immune Cell Function and Interaction (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Immunotherapy and Immune Responses (4 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Immunology and Allergy (96 citations), Genetics (308 citations), Oncology (245 citations), Immunology (160 citations) and Molecular Biology (330 citations). Mitchell Finer has collaborated with scholars based in United States, Netherlands and Malaysia. Frequent co-authors include Helga Boedtker, Qing Wang, Paul Doty, Sirpa Aho, James G. McArthur, Louis C. Gerstenfeld, Ryan McGuinness, Keegan S. Cooke, Margo R. Roberts and Krisztina M. Zsebo. Their work appears in journals such as Nucleic Acids Research, Cancer Research, Molecular and Cellular Biology, Human Gene Therapy and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.